SLRN Acelyrin
- 4.930
- -0.160-3.14%
Acelyrin News
Acelyrin | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. Rowe Price Investment Management, Inc.(10.5%)
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Officer Labrucherie Gil M
Acelyrin | 10-Q: Q2 2024 Earnings Report
Acelyrin | 8-K: ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa; Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results
Acelyrin | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(3.922%),Abigail P. Johnson(3.922%)
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Director Becker Daniel J.
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Director SEIDENBERG BETH C
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Director COZADD BRUCE C
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Director Becker Daniel J.
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Director Gosebruch Henry O
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Director Machado Patrick
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Director Svoronos Dawn
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Director TETRAULT LYNN A.
Acelyrin | 8-K: Current report
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Officer Kim Mina
Acelyrin | 8-K/A: Current report (Amendment)
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Officer Pangali Sanam
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Officer Mpofu Shephard
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Officer Gloria Melanie
Acelyrin | 4: Statement of changes in beneficial ownership of securities-Officer Labrucherie Gil M
Analysis
Price Target
No Data
No Data